About: Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 April 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) artículu científicu espublizáu n'abril de 2019 (ast) im April 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована у квітні 2019 (uk) scientific article published on 15 April 2019 (en)
publication date	wds:Q64115674-AAF45F3D-19CB-4D62-A43A-7EBE94114153
publication date	2019-04-15 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64115674-F34B5208-AE0A-4F77-AF81-87C5EC233271
language of work or name	English
cites work	wds:Q64115674-0346FC9E-3423-4AC2-B22D-EF660FF8456C wds:Q64115674-042B1405-FEB1-433C-9A71-E69D846D63D7 wds:Q64115674-16B0DE8D-7E74-46D9-A543-76991C03D5E2 wds:Q64115674-185BA7EA-E292-4C40-943C-84811731EF76 wds:Q64115674-1DE52D03-5341-40F5-98F7-2ECE1DEE586A wds:Q64115674-25607FBD-79DC-45CA-8972-E49DB9A7F8B9 wds:Q64115674-3075F9DC-58A4-4898-B656-4DCD9D56AD97 wds:Q64115674-34244249-FC2B-4B08-9632-E6158486726F wds:Q64115674-391CA396-8F17-42A8-9C86-17D38BDCB257 wds:Q64115674-457AAE39-267E-4333-8001-86999A9C228D wds:Q64115674-458121F4-1D45-4B77-80E2-0CECAC20EB66 wds:Q64115674-485B57F8-5805-42F3-991F-E9C678139062 wds:Q64115674-4E0CE19B-B2FA-4C41-9FA6-C74176F943B3 wds:Q64115674-5855081F-5017-4EE7-9677-BDA69F370F6F wds:Q64115674-58D4B423-EAC5-4D8C-B897-ACE86C9AAE61 wds:Q64115674-5C3D518F-CC20-4301-822B-4BD069389D3F wds:Q64115674-61E0A7EF-59CD-4E34-B10B-DC64B21C7C29 wds:Q64115674-68712F40-9AAF-4CE2-9F0D-C92EDF9F25E6 wds:Q64115674-7246FF7A-463C-420D-980A-10CD4810A62B wds:Q64115674-73252B29-D706-494E-8417-EC201EFC6D6D wds:Q64115674-7C30A75A-0040-4CFC-B7B2-2DDA85B6583A wds:Q64115674-817679CB-7322-4A4F-8FF7-269109D6C007 wds:Q64115674-856162D9-130B-4237-BD9E-7AE69EEC8FFD wds:Q64115674-85A28EDD-9E34-459E-A2D8-6D82E9B36F99 wds:Q64115674-893ABFFD-7DFE-4CCE-90FC-25FEB85F175F wds:Q64115674-94DCBB55-AADD-4610-9F2E-5790AE0306E6 wds:Q64115674-9E35D3E0-63A1-4C74-9F49-84B08707FA3F wds:Q64115674-A2735CF7-5A34-4EE9-8133-CBB90C10BB55 wds:Q64115674-AFCD11FD-F1E8-4DA4-8213-C1717E63E546 wds:Q64115674-B41BCE91-124E-4F2D-A479-6BF99AFDD730 wds:Q64115674-BE74AAA2-D306-411C-B372-B152305027EC wds:Q64115674-C2CFD9B8-9364-4C20-9A86-E0116F12D52B wds:Q64115674-C59202BC-EFF4-4E0C-A974-0FDAD6603606 wds:Q64115674-C9A50ED1-5F72-44AD-BBCA-B0F15909C410 wds:Q64115674-D1AFAF37-CDE9-4EAF-A37F-A76CAA090269 wds:Q64115674-D462E878-035A-48B7-A2BF-7AF6BF86A3B3 wds:Q64115674-DF6655D9-9E72-46B4-944D-75A2402F6E50 wds:Q64115674-E3E1C01B-DB79-4E2D-A715-FB51805B3DAD wds:Q64115674-F39ACBA0-15E2-4B0A-8957-840F59E72475
cites work	Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy Watson-Crick base-pairing properties of tricyclo-DNA. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them? X chromosome-linked muscular dystrophy (mdx) in the mouse Molecular mechanisms of muscular dystrophies: old and new players Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse Morpholino antisense oligomers: design, preparation, and properties Antisense oligonucleotides: basic concepts and mechanisms NIH Image to ImageJ: 25 years of image analysis Peptide nucleic acids (PNA): synthesis, properties and potential applications The emperor's new dystrophin: finding sense in the noise Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells Eteplirsen for the treatment of Duchenne muscular dystrophy Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide Advantages of 2'-O-methyl oligoribonucleotide probes for detecting RNA targets Oligonucleotide Therapies: The Past and the Present Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges Muscular dystrophies UNA (unlocked nucleic acid): a flexible RNA mimic that allows engineering of nucleic acid duplex stability. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications. Locked nucleic acid as a novel class of therapeutic agents Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy. Translational development of splice-modifying antisense oligomers Personalised genetic intervention for Duchenne muscular dystrophy: antisense oligomers and exon skipping. Exon skipping therapy for Duchenne muscular dystrophy Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy Targeted exon skipping to address "leaky" mutations in the dystrophin gene. Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy Eteplirsen: First Global Approval Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2'-O-Methyl Mixmer Antisense Oligonucleotide Rational Design of Short Locked Nucleic Acid-Modified 2′-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro. Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2'-O-methyl RNA mixmer antisense oligonucleotides for exon skipping in vitro. The case for eteplirsen: Paving the way for precision medicine.
author name string	wds:Q64115674-127D5FB6-3522-4B39-AA72-5FA2F3D5B514 wds:Q64115674-2DA7215A-29BA-409B-B919-62B24EF6C27F wds:Q64115674-7305D86A-A881-4CEB-B26A-DE41DCE96C29
author name string	Rakesh N Veedu Madhuri Chakravarthy Suxiang Chen
rdfs:label	Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro (en) Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro (nl)
skos:prefLabel	Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro (en) Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro (nl)
name	Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software